Aprotinin Inhibits SARS-CoV-2 Replication

Aprotinin Inhibits SARS-CoV-2 Replication

Severe acute respiratory syndrome virus 2 (SARS-CoV-2) is the cause of the current coronavirus disease 19 (COVID-19) pandemic. Protease inhibitors are under consideration as virus entry inhibitors that prevent the cleavage of the coronavirus spike (S) protein by cellular proteases. Herein, we showed...

Full description

Bibliographic Details
Main Authors: Denisa Bojkova, Marco Bechtel, Katie-May McLaughlin, Jake E. McGreig, Kevin Klann, Carla Bellinghausen, Gernot Rohde, Danny Jonigk, Peter Braubach, Sandra Ciesek, Christian Münch, Mark N. Wass, Martin Michaelis, Jindrich Cinatl
Format: Article
Language:English
Published: MDPI AG 2020-10-01
Series:Cells
Subjects:
severe acute respiratory syndrome coronavirus
severe acute respiratory syndrome coronavirus 2
2019-nCoV
COVID-19
antiviral
drug discovery
Online Access:https://www.mdpi.com/2073-4409/9/11/2377

Internet

https://www.mdpi.com/2073-4409/9/11/2377

Similar Items